Passive Heymann nephritis (PHN) is a model of human membranous nephropathy that is characterized by formation of granular subepithelial immune deposits in the glomerular capillary wall which results in complement activation. This is causally related to damage of the filtration barrier and subsequent proteinuria. The local accumulation of injurious reactive oxygen species (ROS) is a major effector mechanism in PHN. ROS may induce tissue damage by initiating lipid peroxidation (LPO). In turn, this leads to adduct formation between breakdown products of LPO with structural proteins, such as formation of malondialdehyde (MDA) or 4-hydroxynonenal-lysine adducts. To examine the role of LPO in the development of proteinuria we have localized MDA and 4-hydroxynoneal-lysine adducts in glomeruli of PHN rats by immunofluoresence microscopy, using specific monoclonal antibodies. By immunogold electron microscopy, MDA adducts were localized to cytoplasmic vesicles and cell membranes of glomerular epithelial cells, to the glomerular basement membrane (GBM), and also to immune deposits. Type IV collagen was specifically identified as being modified by MDA adducts, using a variety of techniques. Collagenase pretreatment of GBM extracts indicated that the NC-1 domain of type IV collagen was a site of adduct formation. When LPO was inhibited by pretreatment of PHN rats with the antioxidant probucol, proteinuria was reduced by -85%, and glomerular immunostaining for dialdehyde adducts was markedly reduced, even though the formation of immune deposits was not affected. By contrast, lowering of the serum cholesterol levels had no influence on the development of proteinuria.
injurious reactive oxygen species (ROS) is a major effector mechanism in PHN. ROS may induce tissue damage by initiating lipid peroxidation (LPO). In turn, this leads to adduct formation between breakdown products of LPO with structural proteins, such as formation of malondialdehyde (MDA) or 4-hydroxynonenal-lysine adducts. To examine the role of LPO in the development of proteinuria we have localized MDA and 4-hydroxynoneal-lysine adducts in glomeruli of PHN rats by immunofluoresence microscopy, using specific monoclonal antibodies. By immunogold electron microscopy, MDA adducts were localized to cytoplasmic vesicles and cell membranes of glomerular epithelial cells, to the glomerular basement membrane (GBM), and also to immune deposits. Type IV collagen was specifically identified as being modified by MDA adducts, using a variety of techniques. Collagenase pretreatment of GBM extracts indicated that the NC-1 domain of type IV collagen was a site of adduct formation. When LPO was inhibited by pretreatment of PHN rats with the antioxidant probucol, proteinuria was reduced by -85%, and glomerular immunostaining for dialdehyde adducts was markedly reduced, even though the formation of immune deposits was not affected. By contrast, lowering of the serum cholesterol levels had no influence on the development of proteinuria.
These findings are consistent with the premise that ROSinduced glomerular injury in PHN involves LPO and that this results not only in damage of cell membranes but in modification of type IV collagen in the GBM as well. The close temporal correlation of the occurrence of LPO with
Introduction
Membranous nephropathy is an immune disease of the human kidney glomerulus that frequently leads to glomerular scarring and chronic renal insufficiency, necessitating renal replacement therapy by chronic dialysis or kidney transplantation (1) . Pas- sive Heymann nephritis (PHN)' is a classical experimental model of membranous nephropathy which is induced in rats by injection with heterologous antibody against a crude autologous tubular antigen, Fx1A (for reviews see references 2 and 3). The hallmarks of both the human and the rat diseases are the development of subepithelial immune deposits in the glomerular capillary walls and heavy proteinuria which commences in PHN 5-7 d after injection of nephritogenic antibody (1) (2) (3) .
The basic molecular mechanisms by which the typical subepithelial immune deposits are formed in PHN have become apparent (3) (4) (5) (6) , but the pathogenesis of proteinuria is unknown, although several steps of functional importance have been explored recently. For example, treatment of rats with oxygen radical scavengers efficiently reduced proteinuria while the formation of immune deposits was not affected (7) . In PHN the glomerular epithelial cells express cytochrome b558 (8) , an integral component of the NADPH-oxidoreductase enzyme complex that is essential for the respiratory burst in activated neutrophilic granulocytes (9) . This enzyme complex generates reactive oxygen species (ROS) locally which are distributed within the glomerular basement membrane (GBM) of proteinuric rats with PHN (8) . ROS cause tissue injury directly, such as by cleavage of peptide bonds (10), or indirectly by initiating myeloperoxidase-H202-halide reactions ( 11), or by lipid peroxidation (LPO) which results, among other consequences, in the generation of highly reactive aldehydes which can then complex with lysine residues of proteins (10) (11) (12) (13) . Since there is evidence for the involvement of ROS in experimental renal diseases (7, 8, 11, 14, 15) , we have examined the contribution of LPO to the development of proteinuria in PHN.
Methods
Induction of PHN and reduction ofproteinuria by probucol. PHN was induced in 220-250-g male Sprague-Dawley rats by intravenous injection of 0.5 ml of sheep anti-FxlA serum as described (8) . Normal rats and those injected 7 d previously were studied. Proteinuria was determined by Bradford assay ( 16) . Probucol (Merrell Dow Pharmaceuticals Inc., Cincinnati, OH), a synthetic antioxidant structurally closely related to butylated hydroxytoluene (BHT) and known to inhibit LPO (17) (18) (19) , was administered to rats for 21 d before the induction of PHN by mixing with standard rat chow at 1% by weight. Rats were found to consume -25 g of powdered pelleted food each per day in lead-in experiments conducted to ensure acceptance of this form of feeding. Additional rats (n = 11 ) were fed with the HMG CoA reductase inhibitor simvastatin (1 mg/d) (Merck Sharp & Dohme, St. Louis, MO), for 21 d, to reduce serum cholesterol to match the cholesterol lowering produced by probucol. 7 d after induction of PHN, the rats were housed in metabolic cages to collect urine for the quantitation of 24-h proteinuria and were then killed. The kidneys were perfused in situ with 4% paraformaldehyde/7% sucrose/50 iM BHT for immunohistochemistry (8) .
The use of rats in these experiments was approved by the Commission for Animal Research at the University of Vienna, by the Austrian Ministry of Science, and by the Animal Ethical Committee of the Wellington School of Medicine.
Antibodies. The mouse monoclonal antibody MDA-2 was raised against murine malondialdehyde (MDA)-LDL and was specific for MDA-lysine adducts (20) . A polyclonal guinea pig anti-MDA antiserum with similar specificity was raised against autologous MDA-LDL (20, 21) . The mouse monoclonal antibody NA5 with specificity for 4-hydroxynonenal (4-HNE) was raised using murine 4-HNE modified LDL (20) (21) (22) . F(ab')2 goat anti-guinea pig Ig/FITC (Dako Corp., Carpinteria, CA) was absorbed with rat serum and shown to have reactivity only with guinea pig immunoglobulins.
Immunofluorescence microscopy. 1-jim-thick frozen sections were cut on a Reichert Ultracut ultramicrotome (Leica-Reichert, Vienna, Austria), using an F4 cryo attachment, from kidneys of normal control rats, 7-d PHN rats, and 7-d PHN rats pretreated with either probucol or simvastatin. The kidneys were fixed by perfusion with freshly prepared 4% paraformaldehyde/7% sucrose/50 M BHT as described (8) . Sheep IgG was detected by direct immunofluorescence microscopy using F(ab' )2 rabbit anti-sheep IgG (Jaxell Accurate, Westbury, NY). Some sections were incubated successively with 1% deoxycholate for 15 min and 1% Triton X-100 for 30 min to provide basement membrane preparations free of cells, followed by washing in Tris-buffered saline (TBS) and quenching by 1:10 diluted normal goat serum in TBS. The sections were treated with a four-layer sandwich for amplification of the signal (8) Immunogold electronmicroscopy. Immunogold electronmicroscopy was performed as described (8, 23, 24 Immunoblotting. Glomeruli were isolated by graded sieving, and lysates were prepared in reducing SDS sample buffer as described (8, 25) . After Radiolabeling ofMDA-Schiff bases in GBMs and immunoprecipitation. Glomeruli from six kidneys of normal controls and 7-d PHN rats were isolated by graded sieving, using TBS with 1% BSA and protease inhibitors (10 Mg/mI of pepstatin, antipain, and leupeptin, and 10 mM diisopropyl fluorophosphate and benzamidine), as described (8, 25) , and 50 MM BHT. GBMs were prepared by extraction with 2% deoxycholate in 20 mM Hepes buffer, pH 7.4, sonication, vortex mixing, centrifugation at 2,000 g for 5 min, and washing in TBS. 3H-labeling of Schiff bases (26), electrophoresis, and autoradiography of labeled proteins were performed as follows: briefly, 3H-sodium cyanoborohydride (Amersham International, Buckinghamshire, UK) was added to the suspended isolated GBMs (2.5 mCi per GBM preparation) in TBS, pH 7 .2, and shaken overnight at 20°C. After washing, 200 IlI of reducing SDS sample buffer (3.6% SDS, 2% /3-mercaptoethanol, 20 mM Tris phosphate buffer, pH 6.8, 10 mM EDTA) was added, heated to 100°C, and aliquots were applied to 5-12% gradient polyacrylamide SDS gels. After electrophoresis, the gels were fixed in propanol/water/acetic acid (25:65:10) for 30 min and then placed into Amplify fluorographic reagent (Amersham International) for 30 min before drying. The gels were then applied to X-Omat AR film (Eastman Kodak Co., Rochester, NY) in film cassettes with amplification screens and exposed for 1 h to 7 d at -800C.
For immunoprecipitation the radiolabeled GBMs were extracted for 45 min with 500 Il 1% SDS, 1% f3-mercaptoethanol, 10 mM EDTA in 20 mM Tris/HCl, pH 7.4, at 20°C, sonicated, and boiled, and the supernatants were lyophilized. The dried proteins were dissolved in a radioimmunoprecipitation buffer (4, final detergent concentrations were 0.1% SDS, 1% Triton X-100, and 1% deoxycholate) and incubated with rabbit antibodies specific for laminin and type IV collagen and against rat glomerular heparan sulphate proteoglycan (gift of Dr. J. Stow, Department of Pathology, Massachusetts General Hosptial, Boston, MA) using -5 jig antibody/200 il labeled GBMs at 4°C overnight. Immune complexes were collected with protein A-Sepharose (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) and were electrophoresed on 3.6-8% gradient SDS gels. Autoradiography was performed as described above.
Detection ofMDA in the NC-I domain of type IV collagen. Glomeruli isolated from 7-d PHN and control rats were suspended in 20 mM Hepes, pH 7.4, containing 2% deoxycholate. Thereafter the preparation proceeded in the following steps: (a) the mixture was subjected to three cycles of sonication (5 min at 20 kc/s), followed by vigorous vortex mixing. After centrifugation at 11,000 g for 5 min, the supernatant was removed, and the pellet was resuspended in Hepes/deoxycholate buffer and centrifuged. (b) Supernatants were combined, sodium cyanoborohydride (2.8 mg/mg wet wt of glomeruli) was added, and reduction was performed overnight at 4°C. The reaction was stopped by the addition of glacial acetic acid (30 yl/ml), dialyzed against 2 liters of 50 mM acetic acid, and lyophylized. (c) The reduced extract was resuspended in 1 ml of 1% SDS, 1% /3-mercaptoethanol, 10 mM EDTA, 20 mM Clostridial collagenase (Millipore Corp., Bedford, MA) (448 U/mg) at 5 mg/ml was added, at a ratio of 1:100 by volume, and digestion proceeded at room temperature for 6 h before termination by the addition of EDTA. (e) Polyclonal anti-NC-i IgG (Heyl Company) was added at a final dilution 1:30, and the mixture was shaken for 12 h at 4°C.
The immunoprecipitate was pelleted by centrifugation at 11,000 g for 5 min and dissolved in 62.5 mM Tris/HCl, pH 6.8, 20% glycerol, 2% SDS, and 0.0025% bromophenol blue before electrophoresis on a 4-15% gradient SDS-gel. (f) Proteins were transferred onto Immobilon (Millipore Corp.), using a semidry transfer apparatus (Bio-Rad Laboratories, Richmond, CA). The membrane was blocked overnight in PBS, 0. 1% Tween 20, 2% BSA at 4°C, washed five times, and then incubated with monoclonal anti-MDA IgG (-15 jig/ml) in the same buffer, followed by five washes. The membranes were incubated for 2 h at 20°C with anti-mouse immunoglobulin conjugated with biotin (Amersham Corp., diluted 1: 1,000). After washing overnight, membranes were incubated with streptavidin-biotin-horseradish peroxidase conjugate (Amersham Corp., 1:1,000) and detected by enhanced chemiluminesence (Amersham Corp.).
Measurement of cholesterol concentrations in rat serum. Normal rats and those developing PHN with and without pretreatment with probucol or simvastatin had serum cholesterol concentrations measured by a cholesterol oxidase method (27) before induction of PHN and at 7 d after anti-FxlA antibody injection.
Statistical methods. Nonparametric Wilcoxon signed rank methods were applied to determine the significance of quantitated proteinuria and cholesterol levels.
Results
Localization ofadducts in glomeruli. Granular immune deposits of sheep IgG in the peripheral capillary loops typical of PHN were detected 7 d after intravenous injection of anti-Fx1A antibody (Fig. 1 A) . Similar immune deposits were observed in PHN rats that were pretreated with probucol or simvastatin (not shown). The kidneys taken from proteinuric PHN rats demonstrated a diffuse granular deposition of MDA-modified proteins in the glomerular epithelial cells and in the peripheral capillary loops when stained with monoclonal antibody MDA-2 ( Fig. 1 B) . Granular staining was also observed in the mesangium and in the cytoplasm and the brush border region of proximal tubules (Fig. 1 B) . Glomerular labeling was almost completely absent in normal controls and was markedly reduced in rats developing PHN after pretreatment with probucol ( Fig. 1  C) . Staining for MDA adducts was not affected by simvastatin pretreatment (not shown). The polyclonal guinea pig anti-MDA antibody, as well as the monoclonal antibody to 4-HNE, stained glomeruli of rats with 7-d PHN in a similar pattern, but with reduced intensity when compared with that of the monoclonal antibody MDA-2 (not shown).
MDA adducts were localized within vesicles and the cytoplasm of glomerular epithelial cells by immunogold labeling on ultrathin frozen sections of formaldehyde-fixed kidneys (Fig.  2) . Gold particles were also detected along the cell membranes of the glomerular epithelial cells which face the GBM, especially in the proximity of immune deposits (Fig. 2, A, B , and E). Labeling of cytoplasmic vesicles was also observed to a lesser extent in mesangial and endothelial cells. Control preparations in which the first antibodies were excluded showed no labeling (not shown).
Localization ofadducts in isolated GBMs. Detergent extraction of unfixed cryostat sections resulted in complete dissolution of the cellular material, leaving basement membranes attached to the slides. The GBMs of proteinuric rats with 7-d PHN showed a fine granular, almost linear, fluorescent signal when immunolabeled for MDA adducts (Fig. 3, right) , but basement membranes from normal controls were almost negative (Fig.  3, left) (Fig. 4) . The guinea pig anti-MDA and anti-4-HNE IgG antibodies bound to bands of similar molecular size (not shown). Immunostaining of normal glomerular proteins, which were processed in parallel under exactly the same conditions, revealed only trace staining of the -220-kD band with MDA-2 antibody (Fig. 4) a weaker -440-kD band were shown to have incorporated radioactivity in normal GBMs (Fig. 6, lane C) . Incorporation of 3H-label into these bands was greatly enhanced in GBMs from 7-d PHN rats with proteinuria (Fig. 6, lane D) . When solubilized radiolabeled GBMs of 7-d PHN rats were immunoprecipitated with antibodies to type IV collagen, the -220-kD and the -440-kD bands were specifically bound (Fig. 6, lane E sulfate proteoglycan, and fibronectin failed to bind any radiolabeled GBM proteins (Fig. 6, lanes F and G) . These data demonstrate that modification of type IV collagen by MDA is greatly enhanced in the 7-d PHN rat glomerulus.
MDA adduct formation on the NC-i domain. The NC-I domain was liberated from GBM type IV collagen by collagenase treatment, and was identified as a 54-kD fragment (under nonreducing conditions) by immunoblotting, using an NC-I domain-specific antibody. When isolated from 7-d PHN rat glomeruli and enriched by immunoprecipitation with anti-NC-i antibody, MDA-2 antibody specifically bound to this same 54-kD fragment (Fig. 7, lane B) , thereby indicating the presence of MDA adducts on the NC-I domain.
Probucol inhibition ofproteinuria. As listed in Table I , the mean 24-h proteinuria in 6 PHN rats was 161.0±24 mg, compared with that of 11 probucol pretreated PHN rats which was significantly less (24.8±8.0 mg, P < 0.01). Rats pretreated with simvastatin (n = II) to achieve similar serum cholesterol levels at induction of PHN as those measured in rats given probucol did not show a significant reduction in 24-h proteinuria (216±18.5 mg, P > 0.05).
Mean serum cholesterol level of 10 normal control rats was 2.28±0.04 mM/liter. Probucol-and simvastatin-treated rats at initiation of PHN were 1.97±0.01 and 1.95+0.01 mM/liter, respectively (P > 0.05), values significantly lower than those of normal rats (P < 0.05) and those of 7-d PHN rats without pretreatment (4.27±0.02 mM/liter, P < 0.01). However, in both probucol-and simvastatin-treated PHN rats, mean serum cholesterol values were decreased at day 7 after injection of anti-Fx1A antibody when compared with unmanipulated PHN rats (P < 0.05). These experiments indicate that the lowering of mean serum cholesterol levels per se in rats with PHN did not prevent the development of the proteinuria. In contrast, inhibition of LPO by probucol markedly ameliorated the proteinuria.
Discussion
Proteinuria is the major consequence of glomerular injury in membranous nephropathy, as well as in other forms of immunologic renal diseases. In PHN, an experimental form of membranous nephropathy in rats, the development of proteinuria depends mainly on the local formation of the C5b-9 membrane attack complex of complement (for review see reference 28) and production of ROS by glomerular cells (7, 8) . In this study we provide evidence for the ROS-mediated formation of LPO adducts on type IV collagen of the GBM and for their relevance in the pathogenesis of proteinuria.
ROS are produced in PHN in situ by intrinsic glomerular cells, especially by the epithelial cells, and then diffuse into the GBM (8) . This raised the question of whether or not LPO occurred in this setting and if and where LPO-mediated adduct formation was localized. To address these questions we have used antibodies specific for characteristic LPO-induced adducts, MDA-lysine or 4-HNE-lysine, that result from the formation of Schiff bases of highly reactive aldehydic fragments of oxidized polyunsaturated fatty acids and of E-amino groups of the lysine residues within proteins (29) . These antibodies were originally generated to document the presence of oxidized LDL (20, 21) and do not show reactivity with native, unoxidized LDL or other unmodified proteins (20) . Furthermore, competition studies have indicated that these antibodies recognize the adducts when present on a variety of different proteins (20) (21) (22) . With these reagents we localized MDA and 4-HNE adducts in highest concentration within glomeruli of proteinuric rats with PHN, whereas reactivity with normal rat glomeruli was minimal, indicating that LPO occurs within PHN glomeruli, in temporal correlation with proteinuria.
The precise localization of the MDA adducts in glomeruli of proteinuric PHN rats was investigated by immunogold electron microscopy. MDA-modified proteins were found in highest concentration in glomerular epithelial cells, particularly in association with membranes of cytoplasmic vesicles, as well as along the glomerular epithelial cell membrane that faces the GBM, and in proximity to immune deposits, in agreement with the granular distribution of MDA adducts observed by immunofluorescence microscopy. A simple, and the most likely, explanation for these observations is that the LPO-mediated adducts are produced locally within the capillary walls. It is also conceivable, but not likely, that the immunohistochemical signal is derived from MDA-modified proteins which were taken up by the glomerular epithelial cells from the circulation.
Immunogold electron microscopy applied to intact renal tissue is not able to completely distinguish adducts associated with the GBM from those on epithelial cell membranes. We therefore isolated basement membranes by removal of the cellular material with detergents from cryostat sections of rat kidneys. When incubated with anti-MDA antibodies, specific immunolabeling was found in the GBMs of proteinuric rats, but not in normal controls, thus providing evidence for the accumulation of LPO adducts within the matrix of the GBM in proteinuric rats.
These findings raised the intriguing possibility that LPO adduct formation could directly affect matrix proteins of the GBM and could impact on the molecular basis of proteinuria. To determine which matrix protein(s) was modified by LPO adduct formation, we have compared the pattern and quantity of MDA-modified glomerular matrix proteins of normal and proteinuric rats by immunoblotting. We noted that several proteins from lysates obtained from proteinuric PHN rats bound anti-MDA and anti-4-HNE antibodies. The largest amount of MDA adducts was associated with a protein with an apparent molecular mass of -220 kD. The intensity of labeling of this protein was greatly increased in lysates of proteinuric glomeruli, when compared with normal controls, thus suggesting that this molecule is modified by MDA adducts. Further evidence of the importance of the -220-kD protein as a site of MDA modification was obtained independently by experiments using isolated GBMs of normal and proteinuric rats with 7-d PHN, in which Schiff base formation was demonstrated by incorporation of 3H-cyanoborohydride (26). When solubilized radiolabeled GBM matrix proteins from proteinuric PHN rats were loaded onto SDS gels and autoradiographed, Schiff base formation was confined again to a prominent -220-kD protein, and to a lesser extent to a -440-kD protein, whereas relatively small amounts of 3H were incorporated into normal GBMs. Clearly, a -220-kD GBM matrix protein is a site of LPO adduct formation in proteinuric PHN~rat glomeruli; other additional matrix proteins may also be modified by LPO but were not identified here.
The MDA-modified -220-kD and 440-kD proteins were determined to be type IV collagen components by immunoblotting and by immunoprecipitation of 3H-cyanoborohydride-labeled lysates of isolated GBMs from proteinuric rats with type IV collagen-specific antibodies. Antibodies to laminin, heparan sulfate proteoglycan, and fibronectin failed to bind any radiolabeled matrix molecule, indicating that of the major GBM matrix components tested, type IV collagen appears to be most intensely modified by MDA-Schiff bases. It is plausible that the -220-kD band observed corresponds to an al-chain monomer of type IV collagen, and the 440-kD band to a dimer. This is consistent with the finding that MDA is a highly reactive dialdehyde which is known to dimerize proteins, for example serum albumin in iron-overloaded rats (30) .
Amino acid sequencing of type IV collagen has revealed that the noncollagenous, globular NC-1 domain is particularly rich in dibasic amino acids which are responsible for the high isoelectric point of this fragment (31 (17) (18) (19) . Probucol is known to partition into cell membranes in vitro and in vivo, and to bind to circulating low density lipoprotein (32) . In this study we have shown that pretreatment of rats with probucol inhibited proteinuria by > 80% and profoundly reduced the amount of MDA adducts in glomeruli, as observed by indirect immunofluorescence microscopy with specific antibody. This occurred even though the formation of immune deposits was not affected in the probucol-treated rats and indicates that probucol inhibited events occurring after local immune complex formation. These observations, in conjunction with our biochemical and immunomorphological data, strongly support a role for LPO in the development of proteinuria in PHN.
Since probucol significantly lowered the mean serum cholesterol levels in normal and PHN rats, we examined the relevance of the hypercholesterolemia that accompanied PHN to the development of proteinuria, although the elevation of serum cholesterol has not been shown to induce acute renal injury or proteinuria. However, evidence is accumulating that chronic hyperlipidemia may contribute to the development of chronic glomerular injury (33) (34) (35) . By contrast, hypercholesterolemia follows the development of proteinuria in PHN. When rats were pretreated with simvastatin and mean serum cholesterol levels were reduced to a value similar to that obtained by probucol pretreatment, no ameliorating effect on the development of proteinuria in PHN was observed. Simvastatin-pretreated PHN rats were not hypercholesterolemic at 7 d when proteinuric, unlike unmanipulated PHN rats. These observations suggest that, after in situ glomerular immune complex formation, locally produced ROS exert their damaging effect on the glomerular capillary wall to a large extent by means of locally initiated LPO and that probucol pretreatment inhibits this process with a consequent reduction in proteinuria. Hyperchelesterolemia is not required for this process to occur, though it may be exaggerated if present. It should, however, be emphasized that formation of adducts could be only one of several reactions which are consequences of local lipid peroxidation with GBM components.
It is intriguing that the LPO adduct formation in the GBM matrix could be a further example of the involvement of type IV collagen, and in particular of its NC-I domain, in the pathogenesis of renal disease. Other examples are in situ GBM immune complex formation in Goodpasture's syndrome, the nephritogenic antigen residing in the a3 chain within the NC-1 domain of type IV collagen (36) , and amino acid sequence aberrations in the NC-1 domain in Alport's syndrome (37) . It appears therefore that LPO-mediated or direct immune injury to components of the NC-1 domain or alterations in its structure are associated with various types of glomerular damage and could provide a common target of glomerular capillary wall injury in various otherwise unrelated diseases. Thus, it will be of considerable interest to examine the relevance of LPOmediated glomerular damage in other experimental systems and in human renal diseases in particular.
